Hexachloro-1,3-butadiene (HCBD) is a potent nephrotoxicant that selectively damages the straight portion (pars recta) of the proximal tubule in the rat. To determine its effects on carcinogenesis, HCBD was administered for 30 wk at a concentration of 0.1% by weight in basal diet to male \Vistar rats previously given 0.1% N-ethyl-N-hydroxyethylnitrosamine (EHEN) in the drinking water for 2 wk. The combined treatment resulted in a significantly higher incidence of renal cell tumors than when EHEN was administered alone. This chronic exposure and a short course of a 0.2% HCBD diet for 3 wk caused marked increase in the numbers of bromodeoxyuridine-incorporating cells or proliferating cell nuclear antigen-positive cells in the outer stripe of the kidney. The ability of HCBD to promote EHEN-initiated renal tumorigenesis in rats thus appears to be associated intimately with linked nephropathy and subsequent cell proliferation.
INTRODUCTION
Many naturally occumng human and animal tumors are associated with chronic tissue damage (5, 6, 15) and its resultant increased levels of cell proliferation and hyperplasia (29, 30) . Nephrotoxic agents may thus be very important factors for renal carcinogenesis. Tbbular regeneration caused by nephrotoxic agents is often accompanied by proliferation of mesenchymal elements such as fibroblasts and capillaries, which may result in a changed cytokine environment (28).
Hexachloro-1,3-butadiene (HCBD) (3 l), a by-product in the synthesis of trichloroethene and perchloroethene, persists in the environment because it is chemically inert. It is a potent nephrotoxicant that selectively damages the straight portion (pars recta) of proximal tubules in the rat (3, [21] [22] [23] 31) . Halogenated alkenes such as HCBD are substrates for hepatic glutathione-s-transferase and are then metabolized by renal y-glutamyltransferase and dipeptidases to cysteine S-conjugates. These conjugates may be directly acting nephrotoxins or they may undergo further bioactivation mediated by p-lyase (9, 30) . (EHEN) is well established as a carcinogen in the rat kidney, where it induces only renal tubular cell tumors (12, 18, 38, 44) . After 30 wk, renal cell adenomas were found in about 40% of rats given drinking water containing 0.1 % EHEN for 2 wk (44) . There are several reports of modification of EHEN-induced renal cell tumor development in rats. , basic lead acetate (17), and trisodium nitrilotriacetate monohydrate (Na3NTA-H,0) (20) are nephrotoxins that cause degeneration of proximal convoluted tubules.
N-Ethyl-N-hydroxyethylnitrosamine
A subthreshold level of a carcinogen alone cannot induce tumors. However, in combination with promoting stimuli, renal tumors may result. The purpose of the present study was to investigate the effect of low doses of HCBD after initial administration of EHEN. An assessment of nephrotoxicity and cell proliferation was included. To estimate the nuclear DNA synthesis in defined tubular segments in tissue sections, immunostaining for endogenous proliferating cell-. nuclear antigen (PCNA) and exogenously applied bromodeoxyuridine (BrdU) was performed.
MATERIALS AND METHODS

Experiitiental Aiiiitials
Male Wistar rats (Std: Wistar) were purchased at 6 wk of age from Nihon SLC (Shizuoka, Japan) and housed in plastic cages (3 ratslcage) with wood chips for bedding in an air-conditioned room at 22 * 2°C and a humidity of 50% with 12-hr lightldark cycle. All animals were cared for in accordance with the principles outlined in the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Rats were weighed every week and fed on standard Oriental MF diet (Oriental Yeast Co., Tokyo, Japan) except during the drug treatment period and allowed free access to tap water throughout.
Test Chemicals
EHEN (CAS: [3] 47-25-6, 2-(ethylnitrosamine) ethanol, purity = 99.8%, liquid at room temperature) and HCBD (purity > 99+%) were purchased from Nakarai Chemical Ltd., Kyoto.
Experiiiieiit I
HCBD was mixed in standard Oriental MF diet at concentrations of 0.2%, 0.04%. and 0.008% with 1% corn 361 oil. Twelve rats were divided into 4 groups (1-4) of 3 rats each and received 0.2% HCBD diet, 0.04% HCBD diet, 0.008% HCBD diet, and the basal diet, respectively, for 3 wk. Whole body weights were recorded every week, and rats were euthanatized under ether anaesthesia at week 3. The kidneys and the liver were immediately removed and weighed and then fixed in 10% neutral formalin. Kidneys were cut into 4 sagittal sections and embedded in paraffin.
Histology. Pairs of formalin-fixed, paraffin-embedded sections of 4 pm thickness were serially cut. The first section of the pair was routinely stained with hematoxylin and eosin (H&E) for histopathological diagnosis. Microscopical examinations were done without knowledge of the treatment groups.
Iinmimohistocheniical Staining of PCNA. The second of the serial sections was deparaffinized and washed in ethanol for PCNA staining. Endogenous hydrogen peroxide activity was blocked with 0.5% methanolic hydrogen peroxide, and after washing, sections were incubated with normal rabbit serum to block nonspecific antibody binding. PCNA staining was performed by the streptavidin biotin (ABC) method (ABC kits, Burlingame, CA) using a commercial PCNA PC clone (Dako, Carpinteria, CA) for immunohistochemical studies of cell proliferation and DNA synthesis. Satisfactory staining, confined to the nucleus, was noted with sections incubated with the primary antibody at a 150 dilution for 1 hr. The chromogen was 3,3'-diaminobenzidine tetrahydrochloride as a 0.05% solution with 0.01% hydrogen peroxide. Sections were counterstained with hematoxylin for microscopic examination.
Determination of PCNA Labeling Indices. The number of PCNA-labeled tubular cells per square millimeter was counted histochemically in 10 randomly selected areas in the renal cortex and the outer stripe in each kidney.
Experintent 2
Eighty-four rats were divided into 4 groups and given the following diets; group I (21 rats) was given 0.1% EHEN in tap water for 2 wk and then 0.1% HCBD diet for 30 wk; group I1 (21 rats) received the basal diet for 2 wk and then 0.1% HCBD diet for 30 wk; group I11 (21 rats) received 1,000 ppm EHEN in tap water for 2 wk and then basal diet for 30 wk; and group IV (21 rats) received the basal diet for 32 wk.
Seruni and Urine Biocheriiical Parameters. Whole body, liver, and kidney weights were recorded for all rats at the termination of the experiment at 32 wk. Urine samples were collected in tubes containing a small amount of sodium azide over an 8-hr period from 3 randomly selected rats in each group immediately before euthanasia., Blood samples for serum biochemistry were taken from the same representative rats from each group under ether anesthesia. The following parameters were measured in serum and urine: blood urea nitrogen (BUN), creatinine, sodium, potassium, and chloride. Biochemical analysis were done by Ina Clinical Laboratory (Iga Ueno, Japan) using clinical analyzers following standard protocols.
Histology. Organs from the remaining rats were preserved in 10% neutral formalin, embedded in paraffin, sectioned, and stained with H&E for histological evaluation. Microscopical examinations were done without knowledge of the treatment groups. The terms employed in the histological classification of lesions in this and earlier studies (17) (18) (19) (20) are simple hyperplasia, adenomatous hyperplasia, and renal cell tumors, which includes both adenomas and carcinomas. There are many synonymous terms for the same morphological entities. Simple hyperplasia is used here to describe the often reversible nonneoplastic cell proliferation induced by nephrotoxins, and focal adenomatous hyperplasia is a possible preneoplastic lesion. These lesions are distinguished on the basis of the presence or absence of a tubular pattern within lumens. The numbers of simple hyperplasia, adenomatous hyperplasia, and renal cell tumors per rat were counted in 4 sagittal sections taken from each kidney.
I~~imiuiohistocheniical Staining for BrdU. Three rats from each experimental group were given a single ip injection of 100 m a g body weight of BrdU (Sigma Chemical Co., St. Louis, MO) 1 hr before euthanasia. All rats were euthanatized under ether anesthesia, and body, liver, and kidney weights were recorded. The kidneys and samples of small intestine from BrdU-treated rats were fixed for 24 hr in 70% ethanol and processed using the ABC method for immunohistochemical studies of cell proliferation and DNA synthesis. Deparaffinized sections were rinsed with distilled water, hydrolyzed with 4 N HCl for 20 min at 37"C, and rinsed with borate buffer, pH 7.6. Denatured sections were treated with 0.01 % trypsin for 3 min at 37°C. Mouse monoclonal anti-BrdU antibody (Becton Dickinson, Rochelle Park, NJ) was used at a dilution of 1:50 with 1 hr of exposure.
Detemiination of BrdV Labeling Indices. The number of BrdU-labeled tubular cells per square millimeter was counted histochemically in 10 randomly selected areas with and without preneoplastic and neoplastic lesions in the renal cortex and the outer stripe in each kidney.
Statistical Analysis
Quantitative data were analyzed for statistical significance using Student's t-test for frequency and Fisher's exact test for incidence.
RESULTS
Experiment I
Changes in Body Weights. Changes in body weights are shown in Table I . Body weight of rats treated with 0.2% HCBD in group 1 did not increase over 3 wk. The weight gain in group 3 was similar to that in group 4. At week 3, weight values for groups 1 and 2 were significantly lower than those for groups 3 and 4.
Histopathological Features of Kidneys. Most of the pars recta of the proximal tubules in rats treated with 0.2% HCBD diet was lined with basophilic epithelium, which sometimes formed small clumps; mitotic figures were frequent, indicating extensive regeneration (Fig. 1) .
No such proximal lesions were evident in group 2 or group 3.
PCNA Labeling Indices. The PCNA-positive cells were concentrated in the outer stripe (see Table I 60.9 2 8.3 a n r c e ratdgroup.
b Significantly different (p < 0.01) from the group 1V value. =Significantly different (p < 0.01) from the index for the cortex in the same group. significant increase was observed only for the outer stripe in group 1.
Experimerlt 2
Changes in Body and Kidney Weights. Body and kidney weights are shown in Table 11 . HCBD caused a significant decrease in mean final body weight in groups I and I1 as compared with groups 111 and IV. The mean kidney weight for group I was significantly increased compared with that for group IV. The mean kidney weights relative to body weight in groups I and I1 were significantly higher than those in groups 111 and IV.
Biocheniical Parameters and Analysis. No significant intergroup differences were observed in serum and urine biochemical parameters, such as the BUN, creatinine, sodium, potassium, and phosphate values.
Incidences of Simple Hypeplastic Foci, Adenomatom Hypeplastic Foci, and Renal Cell Tuniors. Simple hy-perplasia presented as small single or multiple tubular structures characterized by increased basophilia (Fig. 2) . A diagnosis of adenomatous hyperplasia (Fig. 3) was made for lesions less than 3 times the size of the glomerulus. Larger lesions were classified as renal cell tumors (Fig. 4) . The criteria used for the diagnosis were based on the classification published by Alden and Kanerva (1) . Incidences of simple hyperplastic foci, adenomatous hyperplastic foci, and renal cell tumors are summarized in Table  111 . Adenomatous hyperplastic foci and renal cell tumors were not found in groups I1 and IV. Incidences of hyperplastic foci and renal cell tumors in group I significantly differed from those in groups I11 and IV.
Midtiplicity of Simple Hyperplastic Foci, Adenomatous Hyperplastic Foci, and Renal Cell Tumors. The numbers of lesions per affected rat (multiplicity) are shown in Table IV. Values for hyperplastic foci and renal cell tumors in group I were significantly greater than those in groups I11 and IV.
BrdU Labeling Indices. The mean numbers of BrdUlabeled cells with or without adenomatous hyperplasia and'adenoma in the kidneys of-'each group are shown in Table V . Significant increase was observed for the outer stripe and cortex of the rats treated with HCBD.
DISCUSSION
Several factors contribute to the mechanism of carcinogenesis, including toxicodynamics, metabolism, DNA alteration, and cell proliferation associated with chemical exposure (11, 16, 26, 27) . The toxicity changes with the magnitude of individual dose, the rate and duration of dosing, and the route of exposure. The toxic effects induced by nongenotoxic compounds play an important role in their renal carcinogenicity.
HCBD is conjugated with glutathione to give S-(pentachlorobutadienyl) glutathione (33, 47). which is nephrotoxic in rats in vivo and cytotoxic in rat kidney cells (32). Because of much higher activity of glutathione Stransferases catalysing S-(pentrachlorobutadienyl) glutathione in the rat liver, the formation of toxic glutathione S-conjugates is presumed t o take place predominantly in liver. S-(pentachlorobutadienyl) glutathione is reabsorbed from the gut, partially after metabolism by intestinal yglutamyltranspeptidase and dipeptidases to S-(pentachlo-robutadieny1)-L-cysteine, and finally translocated to the kidney. S-(pentachlorobutadieny1)-L-cysteine and the corresponding mercapturic acid accumulate in the kidney because of the presence of an organic anion transporter, and the mercapturate is metabolized by acylase to S-(pen-tachlorobutadieny1)-L-cysteine, which is finally cleaved by cysteine conjugate P-lyase to a reactive thioketene (8). Covalent binding of this reactive intermediate to macromolecules presumably initiates a cascade of events finally resulting in toxicity (36, 37).
A variety of chemicals have been shown to cause male rat-specific nephrotoxicity as excessive accumulation of hyaline droplets in renal proximal convoluted tubule epithelial cells, and it is now established that the hyaline droplets were induced by the accumulation of a,,-globulin in phagolysosomes (42). However, no increases in urinary kidney-type-a,,-globulin were observed in male adult rats treated with HCBD (35).
In the male rat, the LDso of HCBD is about 250-350 mgkg when given orally and 200 mgkg when given ip (14). In experiment 1, mean body weight of rats treated with 0.2% HCBD did not increase over 3 wk, apparently because of reduced consumption of the food in response to the addition of HCBD. Before this study, after 3 days of oral administration of 200 mgkg body weight HCBD, the kidneys of rats showed a distinct band of tubular necrosis in the outer stripe of the outer medulla, extending from the outer stripe to the region where the pars recta of the proximal tubule changes into the thin descending limb of Henle. The major site of increased cell proliferation after chemically induced toxic renal lesions was also shown to be the outer stripe of the outer medulla, or the P, segment of the proximal tubules in rats (39). This mechanism may be hypothesized as underlying tumor promotion by these nongenotoxic chemicals (40).
In this experiment, we used both PCNA expression and BrdU incorporation to examine cell proliferation. BrdU immunolabeling has been particularly useful for detecting low cellular proliferation rate in tissues (13, 25). In contrast, a strong nuclear signal with anti-PCNA depicts only that population of cells that at the time of euthanasia entered the S-phase of the cell cycle (4, 10, 25, 43) .
HCBD has demonstrated some mutagenic potential in (34, 45, 46) . These studies showed that kidney microsomal glutathione S-transferase converts HCBD to active intermediates (N-acetyl-S-pentachlorobutadienyl-L-cysteine and methyl-acetyl-s-pentachlorobutadienyl-D,L-homocysteinate), which have mutagenic potential after bioactivation. However, rats treated with only HCBD for 30 wk in the present study had neither adenomatous hyperplasias nor renal cell tumors, probably indicating that the treatment period was not long enough.
The present results show an enhanced cell turnover during growth of preneoplastic lesion and tumors. The hypothesis that such epigenetic or nongenotoxic events play a role in neoplasia is in line with the established link between wounding and cancer (41).
Chronic exposure to S-(l,2-dichlorovinyl)-~-cysteine also induces regeneration in the P2 segment in the proximal tubule, which is accompanied by a decrease in differentiation and an increase in phenotypic markers more characteristic of embryonic kidney (24, 40). Therefore, some influence on differentiative status may have contributed in the present study. The ability of HCBD to induce EHEN-initiated renal tumorigenesis in rats appears to be associated with nephropathy and subsequent cell proliferation.
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